Biohaven Pharmaceutical Holding Company Ltd.

DB:2VN 주식 보고서

시가총액: €11.0b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Biohaven Pharmaceutical Holding 미래 성장

Future 기준 확인 5/6

주요 정보

72.7%

수익 성장률

71.2%

EPS 성장률

Biotechs 수익 성장35.4%
매출 성장률29.2%
향후 자기자본 수익률n/a
애널리스트 커버리지

Good

마지막 업데이트n/a

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

DB:2VN - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20241,977-7N/AN/A5
12/31/20231,330-512N/AN/A7
12/31/20221,081-948N/AN/A7
6/30/2022860-1,021-579-556N/A
3/31/2022738-791-650-649N/A
12/31/2021463-847-833-831N/A
9/30/2021308-865-852-850N/A
6/30/2021190-889-832-809N/A
3/31/2021106-859-781-758N/A
12/31/202064-767-748-703N/A
9/30/202029-698-638-591N/A
6/30/202011-609-524-497N/A
3/31/20201-639-507-481N/A
12/31/2019N/A-529-381-377N/A
9/30/2019N/A-434-313-310N/A
6/30/2019N/A-390-293-289N/A
3/31/2019N/A-218-167-162N/A
12/31/2018N/A-241-201-197N/A
9/30/2018N/A-213-207-204N/A
6/30/2018N/A-195-179-177N/A
3/31/2018N/A-202-170-169N/A
12/31/2017N/A-139-95-95N/A
9/30/2017N/A-138-70-70N/A
6/30/2017N/A-123-57-57N/A
3/31/2017N/A-83-36-36N/A
12/31/2016N/A-64-30-30N/A
9/30/2016N/A-42-15-15N/A

애널리스트 미래 성장 예측

수입 대 저축률: 2VN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.01%).

수익 vs 시장: 2VN is forecast to become profitable over the next 3 years, which is considered above average market growth.

고성장 수익: 2VN is expected to become profitable in the next 3 years.

수익 대 시장: 2VN's revenue (29.2% per year) is forecast to grow faster than the German market (3.9% per year).

고성장 수익: 2VN's revenue (29.2% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if 2VN's Return on Equity is forecast to be high in 3 years time


성장 기업 발견